Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04291066 · ClinicalTrials.gov registry record · Phase 2
Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients
A Phase 2 study, sponsored by HonorHealth Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT04291066 is a Phase 2 study that has completed, run by HonorHealth Research Institute. The registered enrollment target is 92 participants.
The verdict
NCT04291066, a Phase 2 study, has completed, sponsored by HonorHealth Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
This study will evaluate the administration of N-Acetyl-cysteine in combination with multi-vitamins/minerals in geriatric population (\>60 years of age) who have experienced a traumatic brain injury.
Interventions
- DRUG N-Acetyl cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04291066
The ClinicalTrials.gov registry entry for NCT04291066 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HonorHealth Research Institute, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N-Acetyl cysteine is the first listed.
NCT04291066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04291066 about?
NCT04291066 is a clinical study titled "Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients". This study will evaluate the administration of N-Acetyl-cysteine in combination with multi-vitamins/minerals in geriatric population (\>60 years of age) who have experienced a traumatic brain injury.
What is the current status of trial NCT04291066?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2019-09-01. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT04291066?
The interventions under investigation include: N-Acetyl cysteine (DRUG).
Who is sponsoring clinical trial NCT04291066?
This trial is sponsored by HonorHealth Research Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.